Latest Breaking News On - Curran simpson - Page 1 : comparemela.com

Regenxbio CEO to step down after 15 years

BioPharma

Anabel samimyCurran simpsonEli lillyNovarti zolgensmaDrug administrationKenneth millsRocket pharma

REGENXBIO Inc (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript

REGENXBIO Inc (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesKen mosabiEllie merleAnnabel samimyVikram purohitAlec stranahanSteve pakolaCurran simpsonGena wangPatrick christmasTechnology careersMorgan stanleyRegenxbio incExchange commissionCall transcript mayChief legal

Regenxbio (RGNX) Reports Interim Data from Phase II Bridging Study of RGX-314

Regenxbio (RGNX) Reports Interim Data from Phase II Bridging Study of RGX-314
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPeter kaiserCharlesc wykoffCurran simpsonSteve pakolaOphthalmology for the blanton eye instituteCleveland clinic lerner college of medicineCompany navxpressOphthalmology researchResearch at retina consultants of texasManufacturing innovation centerCole eye instituteRetina consultantsDeputy chairBlanton eye instituteHouston methodist

REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress™ Manufacturing Platform Process

REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpress™ Manufacturing Platform Process
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPeter kaiserChris brinzeyicr westwickeCharlesc wykoffCurran simpsonSteve pakolaDana cormackcorporate communicationsTechnology platformTechnology platform licenseesOphthalmology researchClearside biomedical incManufacturing innovation centerOphthalmology for the blanton eye instituteCleveland clinic lerner college of medicineInnovation centerCompany navxpress

Curran Simpson and Shiva Fritsch | REGENEXBIO | Maryland Daily Record

REGENXBIO Inc. announced the promotion of Curran Simpson from chief technology and operations officer to chief operating officer. In addition, Shiva Fritsch has been elevated to chief communications officer and will continue in her role as chief people officer. Simpson joined REGENXBIO in 2015 with extensive leadership experience across biopharmaceutical operations, manufacturing, supply chain, research .

Curran simpsonCollege parkRegenxbio incUniversity of marylandNovo nordisk biochem incBryn mawr collegeBiogen incGenencor incClarkson universityClarkson college of technologyNovavax incAmerica at glaxosmithklineHuman genome sciences incCovance biotechnology services incGenentech incRoberth smith school of business